. Although this is a recently recognized entity, there had been reports of it previously (Grinblat et al. 1981; Davison et al. 1983) . Epler et al. (1985) , by whom the term of BOOP, now widely accepted, was coined, emphasized that the diagnostic distinction from the spectrum of inf iltrative lung diseases including idiopathic f ibrosing alveolitis is important because most patients with BOOP have a favorable prognosis and response to corticosteroids. Corticosteroids (Basset et al. 1986 ) have been widely used for the treatment of BOOP although a few patients were reported to improve with antibiotics, or spontaneously (Epler et al. 1985) . However, a short course treatment of corticosteroids for BOOP results in a relapse soon after termination of the treatment (Epler et al. 1985; Cordier et al. 1989 suggest that EM is effective in patients with BOOP because of an antiinflammatory action but not of a bacteriocidal effect. The successful treatment of these patients suggests that EM is a useful drug instead of corticosteroids for treatment of BOOP.
